Catalyst Monitor Report: Q1 2026 Outlook: Regulatory Approvals and Late-Stage Trials Signal Strong Pipeline Momentum Across Key Therapeutic Areas

Key market opportunities in Q1 2026 include significant regulatory catalysts like approvals for GSK's depemokimab, Regenxbio's gene therapy, and Omeros' narsoplimab. Ongoing trials by Xenon, Cerevel, ...
Commercial Integrator

First-Ever Ellipsys Catalyst Event to Unite Charter Members & Vendor Partners in Phoenix, Oct. 1-2

Ellipsys Commercial Technology Group plans to hold its first-ever exclusive networking and education event in October for the group’s Charter Members. The Ellipsys Catalyst event, scheduled for Oct. 1 ...
Commercial Integrator

Ellipsys Catalyst 2025 Event Emphasizes Growth & Connection

Ellipsys Commercial Technology Group announced that its annual Ellipsys Catalyst event, held from May 5 to 7, 2025 in Indianapolis, Ind., brought Ellipsys members and vendor partners together from ...
Business Wire

Impartner Champions the Next Era of Partner Leadership at Catalyst 2025

SALT LAKE CITY--(BUSINESS WIRE)--Impartner, the global leader in partner ecosystem solutions, announces its sponsorship of Catalyst 2025, the premier event hosted by Partnership Leaders, taking place ...
Seeking Alpha

Catalyst Watch: Walmart earnings, DraftKings event, REITworld, OPEC update and another CPI nail-biter

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events ...
Nasdaq

Edgewater Wireless Captures Industry Attention at the 2025 Silicon Catalyst Portfolio Update in Silicon Valley

Growing momentum behind Edgewater’s cutting-edge Wi-Fi Spectrum Slicing technology garners strong interest from global partners, strategic advisors and semiconductor industry leaders “Our ...